Nurix Story

<div class='circular--portrait' style='background:#8B008B;color: #ffffff;font-size:4em;'>NT</div>
NRIX -- USA Stock  

USD 37.64  0.28  0.75%

Nurix Stock News module provides quick insight into current market opportunities from investing in Nurix Therapeutics. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Nurix Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Additionally, see Nurix Therapeutics Hype Analysis, Nurix Therapeutics Correlation and Nurix Therapeutics Performance.

Search Today's Stock News

 
Refresh
Nurix Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Nurix daily returns and investor perception about the current pice of Nurix Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Acquisition by Sands Arthur T of 804170 shares of Nurix Therapeutics subject to Rule 16b-3
Filed transaction by Nurix Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Nurix insider trading alert for grant of stock option (right to buy) by Sands Arthur T, President CEO, on 23rd of October 2020. This event was filed by Nurix Therapeutics Inc with SEC on 2020-10-23. Statement of changes in beneficial ownership - SEC Form 4

Net Income

Net Income Comparative Analysis

Nurix Therapeutics is currently under evaluation in net income category among related companies. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Peers

Nurix Therapeutics Related Equities

DTILPrecision BioSciences   10.63   
0%
100.0%
EQEquillium   6.92   
0%
65.0%
EDITEditas Medicine   3.20   
0%
30.0%
EARSAuris Medical Holding   1.05   
0%
9.0%
DRNADicerna Pharmaceuticals   0.13   
0%
1.0%
DNLIDenali Therapeutics   0.19   
1.0%
0%
DMACDiaMedica Therapeutics   1.89   
17.0%
0%
DVAXDynavax Technologies Corporation   4.98   
46.0%
0%
NKNantKwest   5.41   
50.0%
0%
DYAIDYADIC INTERNATIONAL INC   7.57   
71.0%
0%
Additionally, see Nurix Therapeutics Hype Analysis, Nurix Therapeutics Correlation and Nurix Therapeutics Performance. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.